Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,699,224
  • Shares Outstanding, K 190,810
  • Annual Sales, $ 2,759 M
  • Annual Income, $ -1,029 M
  • EBIT $ -220 M
  • EBITDA $ 864 M
  • 60-Month Beta 1.42
  • Price/Sales 6.28
  • Price/Cash Flow 18.33
  • Price/Book 7.81

Options Overview Details

View History
  • Implied Volatility 14.46% (-1.17%)
  • Historical Volatility 2.56%
  • IV Percentile 22%
  • IV Rank 11.38%
  • IV High 76.81% on 08/01/25
  • IV Low 6.45% on 12/08/25
  • Expected Move (DTE 3) 1.49 (1.44%)
  • Put/Call Vol Ratio 0.39
  • Today's Volume 197
  • Volume Avg (30-Day) 368
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 43,210
  • Open Int (30-Day) 41,531
  • Expected Range 101.82 to 104.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.14
  • Number of Estimates 3
  • High Estimate 0.18
  • Low Estimate 0.09
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.00 +1.28%
on 01/20/26
103.54 -0.22%
on 02/10/26
+0.88 (+0.86%)
since 01/16/26
3-Month
66.00 +56.53%
on 11/18/25
103.54 -0.22%
on 02/10/26
+36.16 (+53.85%)
since 11/17/25
52-Week
38.81 +166.18%
on 08/07/25
103.54 -0.22%
on 02/10/26
+54.00 (+109.51%)
since 02/14/25

Most Recent Stories

More News
3 Overrated Stocks That Concern Us

3 Overrated Stocks That Concern Us

EXAS : 103.31 (+0.07%)
TPH : 46.30 (-0.15%)
SIGI : 86.54 (+0.14%)
Exact Sciences: Q4 Earnings Snapshot

Exact Sciences: Q4 Earnings Snapshot

EXAS : 103.31 (+0.07%)
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

Fourth quarter and 2025 highlights Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695...

EXAS : 103.31 (+0.07%)
1 Momentum Stock with Exciting Potential and 2 Facing Headwinds

1 Momentum Stock with Exciting Potential and 2 Facing Headwinds

BPOP : 144.90 (+1.59%)
EXAS : 103.31 (+0.07%)
EL : 112.14 (+3.60%)
Exact Sciences (EXAS): Buy, Sell, or Hold Post Q3 Earnings?

Exact Sciences (EXAS): Buy, Sell, or Hold Post Q3 Earnings?

EXAS : 103.31 (+0.07%)
1 Growth Stock to Stash and 2 We Avoid

1 Growth Stock to Stash and 2 We Avoid

ENVA : 148.36 (-0.51%)
EXAS : 103.31 (+0.07%)
PL : 22.21 (-0.94%)
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests

Passage of MCED legislation marks major milestone for early cancer detection

EXAS : 103.31 (+0.07%)
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide

Milestone underscores test’s significant role as a global standard-of-care in guiding personalized breast cancer treatment The predictive utility of this test helped...

EXAS : 103.31 (+0.07%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS

NEW YORK , Feb. 2, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

FOLD : 14.30 (-0.07%)
EXAS : 103.31 (+0.07%)
RAPT : 57.84 (+0.21%)
JHG : 49.50 (+0.92%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS

NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

EXAS : 103.31 (+0.07%)
PEN : 341.03 (+0.51%)
FFIC : 16.84 (+1.02%)
DBRG : 15.41 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 103.69
2nd Resistance Point 103.55
1st Resistance Point 103.43
Last Price 103.31
1st Support Level 103.17
2nd Support Level 103.02
3rd Support Level 102.90

See More

52-Week High 103.54
Last Price 103.31
Fibonacci 61.8% 78.81
Fibonacci 50% 71.18
Fibonacci 38.2% 63.54
52-Week Low 38.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar